Home › Peripheral Arterial Disease › Texas › San Antonio
Peripheral Arterial Disease clinical trials in San Antonio, TX
3 studies for Peripheral Arterial Disease are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- National Institute of Clinical Research, Inc., San Antonio
- DaVita Clinical Research, San Antonio
- Davita Clinical Research, San Antonio
- and 1 more
SELUTION4BTK Trial
Recruiting
- Texas Cardiac and Vascular Institute San Antonio, San Antonio
Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment
RecruitingObservational studyHealthy volunteers welcome
- University of Texas Health Science Center at San Antonio, San Antonio
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Chicago, IL9 studies
- Dallas, TX9 studies
- Boston, MA9 studies
- Cleveland, OH9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Omaha, NE7 studies
- Nashville, TN6 studies
- Minneapolis, MN6 studies
- Aurora, CO6 studies
- Miami, FL6 studies
- Detroit, MI5 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Colorectal Cancer46 studies
- Breast Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.